Cleared Traditional

K950491 - RICH-MAR CARBON ELECTRODES

K950491 is an FDA 510(k) clearance for RICH-MAR CARBON ELECTRODES, manufactured by Rich-Mar Corp.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 51-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1995
Decision
51d
Days
Class 2
Risk

K950491 is an FDA 510(k) clearance for the RICH-MAR CARBON ELECTRODES. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Rich-Mar Corp. (Inola, US). The FDA issued a Cleared decision on March 29, 1995 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Rich-Mar Corp. devices

FDA 510(k) Submission Details - K950491

510(k) Number K950491 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 1995
Decision Date March 29, 1995
Days to Decision 51 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 148d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 314
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K950491.
32MM NICKEL PLATED DISC ELECTRODE
K953220 · Chalgren Enterprises, Inc. · Oct 1995
MEDI-TRAC EEG ELECTRODE
K950782 · Graphic Controls Corp. · Jun 1995
MODEL 1001, HYDRODOT(TM) NEUROMONITORING SYSTEM WITH E NET(TM) EEG INTERFACE CABLE
K946318 · Physiometrix, Inc. · Apr 1995
CUTANEOUS ELECTRODE
K941986 · Maxxim Medical · Feb 1995
DISPOSABLE CUTANEOUS ELECTRODES
K941799 · Bio-Logic Systems Corp. · Feb 1995
EEG CUP ELECTRODE
K933808 · Cadwell Laboratories, Inc. · Dec 1994